Infection Control Market by Transmission, Products, End-User

List of Tables

The Infection Control Market was valued at USD 43.62 billion in 2023, expected to reach USD 45.79 billion in 2024, and is projected to grow at a CAGR of 5.23%, to USD 62.36 billion by 2030.

Infection control encompasses a range of policies and procedures aimed at inhibiting the spread of infections, especially in healthcare facilities, to protect both patients and healthcare workers. It's a critical dimension of healthcare services, with its scope extending from hospitals and clinics to other environments like community healthcare and residential care facilities. The necessity of infection control became even more pronounced during the COVID-19 pandemic, reinforcing practices like hand hygiene, sterilization, vaccination, and the use of personal protective equipment. Applications span across diverse end-use sectors, including hospitals, ambulatory surgical centers, research laboratories, and more. Key growth determinants for the global infection control market include the rising prevalence of healthcare-associated infections (HAIs), advancements in sterilization and disinfection technologies, heightened awareness and governmental initiatives for infection prevention, and an increased elderly population requiring aged care services. There are significant opportunities such as the surge in demand for single-use medical nonwovens, smart infection control management systems, and the expansion of telemedicine services that offer curated infection control advice. However, the market faces challenges like high costs related to implementing advanced infection control systems, variations in regulatory requirements across regions, and an inadequate number of trained professionals, particularly in developing countries. Innovations concentrated on antimicrobial-coated devices, automated sterilization systems, and data-driven predictive analytics for infection risk assessment could catalyze substantial business growth. The market is currently dynamic, being driven by both public health urgencies and technological innovations, but competition is intensifying as global awareness about infection prevention amplifies. Addressing limitations related to cost and training while capitalizing on technology enhancements can yield positive outcomes in both efficacy and accessibility of infection control solutions. For strategic business maneuvers, collaboration with tech companies to integrate AI and IoT in infection prevention and control may offer competitive advantages.

KEY MARKET STATISTICS
Base Year [2023]	USD 43.62 billion
Estimated Year [2024]	USD 45.79 billion
Forecast Year [2030]	USD 62.36 billion
CAGR (%)	5.23%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Infection Control Market

The Infection Control Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Rising incidence of hospital-acquired infections and surging usage of infection control products
- Increasing number of surgical procedures and need for appropriate safety methods
- Upsurging adoption of infection control products in medical device and pharmaceutical industry
Market Restraints
- Adverse effects associated with chemical based disinfectants
Market Opportunities
- Increasing outsourcing of sterilization services by hospitals, and clinics
- Growing investments by manufacturers in the production of infection control products
Market Challenges
- Availability of substitute products and techniques for infection control

Porter's Five Forces: A Strategic Tool for Navigating the Infection Control Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Infection Control Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Infection Control Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Infection Control Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Infection Control Market

A detailed market share analysis in the Infection Control Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Infection Control Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Infection Control Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Infection Control Market

A strategic analysis of the Infection Control Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, AliMed, Inc., Amway Corporation, Ansell Ltd., ASP International GmbH, Becton, Dickinson and Company, Belimed AG, bioMerieux SA, Cantel Medical Group, Cardinal Health Inc., Codi Group BV, Colgate-Palmolive Company, Dandong Huayang Textile and Garment Co., Ltd., Diversey Holdings Ltd., Ecolab Corporation, Embuer Health Pvt. Ltd., Essity AB, F. Hoffmann-La Roche Ltd., Getinge AB, Go Green Solutions, LLC, GOJO Industries, Inc., Hartmann Group, Jiaxing Hongjie Commodity Co., Ltd., Kao Corporation, Kimberly-Clark Corporation, Matachana Group, Medexter Healthcare GmbH, Medline Industries, LP, MELAG Medizintechnik GmbH & Co. KG, Merck KGaA, Metrex Research, LLC, Nice-Pak Products, Inc., Olympus Corporation, Pal International Ltd., Pfizer Inc., Procter & Gamble Company, Professional Disposables International, Inc., Reckitt Benckiser Group PLC, Rockline Industries Ltd., S. C. Johnson & Son, Inc., Sotera Health LLC, Sterigenics International LLC, Steris Corporation, Unicharm Corporation, Unilever PLC, Weiman Products, LLC, World Precision Instruments, LLC, and Yessor Wipes.

Market Segmentation & Coverage

This research report categorizes the Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Transmission, market is studied across Airborne, Bloodborne, and Contract.
Based on Products, market is studied across Cleaning & Disinfection, Endoscope Reprocessing, Protective Barriers, and Sterilization. The Cleaning & Disinfection is further studied across Disinfectants, Equipment, Formulation, and Level of Disinfection. The Disinfectants is further studied across Hand Disinfectants, Instrument Disinfectants, Skin Disinfectants, and Surface Disinfectants. The Equipment is further studied across Flusher Disinfectors, Ultrasonic Cleaners, UV-Ray Disinfectors, and Washer Disinfectors. The Formulation is further studied across Disinfectant Sprays, Disinfectant Wipes, and Liquid Disinfectants. The Level of Disinfection is further studied across High-Level, Intermediate-Level, and Low-Level. The Endoscope Reprocessing is further studied across Consumables and Equipment. The Protective Barriers is further studied across Covers & Closures, Goggles, and Medical Nonwovens. The Sterilization is further studied across E-Beam Sterilization, Equipment Sterilization, ETO Sterilization, Filtration Sterilization, Gamma Sterilization, Radiation Sterilization, and Steam Sterilization.
Based on End-User, market is studied across Food & Beverage Companies, Hospitals & Clinics, Life Sciences Industry, Medical Device Companies, and Pharmaceutical Companies.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-43676CF42B0E

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising incidence of hospital-acquired infections and surging usage of infection control products
  - 5.1.1.2. Increasing number of surgical procedures and need for appropriate safety methods
  - 5.1.1.3. Upsurging adoption of infection control products in medical device and pharmaceutical industry
- 5.1.2. Restraints
  - 5.1.2.1. Adverse effects associated with chemical based disinfectants
- 5.1.3. Opportunities
  - 5.1.3.1. Increasing outsourcing of sterilization services by hospitals, and clinics
  - 5.1.3.2. Growing investments by manufacturers in the production of infection control products
- 5.1.4. Challenges
  - 5.1.4.1. Availability of substitute products and techniques for infection control
5.2. Market Segmentation Analysis
- 5.2.1. Products: Burgeoning usage of sterilization eliminate all forms of microbial life, including spores to ensure the safety of medical devices
- 5.2.2. End-User: Evolving usage of infection control in hospitals & clinics sector
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Infection Control Market, by Transmission

6.1. Introduction
6.2. Airborne
6.3. Bloodborne
6.4. Contract

7. Infection Control Market, by Products

7.1. Introduction
7.2. Cleaning & Disinfection
- 7.2.1. Disinfectants
  - 7.2.1.1. Hand Disinfectants
  - 7.2.1.2. Instrument Disinfectants
  - 7.2.1.3. Skin Disinfectants
  - 7.2.1.4. Surface Disinfectants
- 7.2.2. Equipment
  - 7.2.2.1. Flusher Disinfectors
  - 7.2.2.2. Ultrasonic Cleaners
  - 7.2.2.3. UV-Ray Disinfectors
  - 7.2.2.4. Washer Disinfectors
- 7.2.3. Formulation
  - 7.2.3.1. Disinfectant Sprays
  - 7.2.3.2. Disinfectant Wipes
  - 7.2.3.3. Liquid Disinfectants
- 7.2.4. Level of Disinfection
  - 7.2.4.1. High-Level
  - 7.2.4.2. Intermediate-Level
  - 7.2.4.3. Low-Level
7.3. Endoscope Reprocessing
- 7.3.1. Consumables
- 7.3.2. Equipment
7.4. Protective Barriers
- 7.4.1. Covers & Closures
- 7.4.2. Goggles
- 7.4.3. Medical Nonwovens
7.5. Sterilization
- 7.5.1. E-Beam Sterilization
- 7.5.2. Equipment Sterilization
- 7.5.3. ETO Sterilization
- 7.5.4. Filtration Sterilization
- 7.5.5. Gamma Sterilization
- 7.5.6. Radiation Sterilization
- 7.5.7. Steam Sterilization

8. Infection Control Market, by End-User

8.1. Introduction
8.2. Food & Beverage Companies
8.3. Hospitals & Clinics
8.4. Life Sciences Industry
8.5. Medical Device Companies
8.6. Pharmaceutical Companies

9. Americas Infection Control Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Infection Control Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Infection Control Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
- 12.3.1. Freudenberg Medical Establishes Second Production Facility In Costa Rica
- 12.3.2. WPT Nonwovens Invests USD 19.5M in Kentucky Manufacturing Facility, Boosting Local Economy
- 12.3.3. Berry Launches Lightweight Tube Closure Solution Catering To The Stringent Safety And Hygiene Standards Mandated In Infection Control Protocols
12.4. Strategy Analysis & Recommendation

Companies Mentioned

1. 3M Company
2. Abbott Laboratories
3. AliMed, Inc.
4. Amway Corporation
5. Ansell Ltd.
6. ASP International GmbH
7. Becton, Dickinson and Company
8. Belimed AG
9. bioMerieux SA
10. Cantel Medical Group
11. Cardinal Health Inc.
12. Codi Group BV
13. Colgate-Palmolive Company
14. Dandong Huayang Textile and Garment Co., Ltd.
15. Diversey Holdings Ltd.
16. Ecolab Corporation
17. Embuer Health Pvt. Ltd.
18. Essity AB
19. F. Hoffmann-La Roche Ltd.
20. Getinge AB
21. Go Green Solutions, LLC
22. GOJO Industries, Inc.
23. Hartmann Group
24. Jiaxing Hongjie Commodity Co., Ltd.
25. Kao Corporation
26. Kimberly-Clark Corporation
27. Matachana Group
28. Medexter Healthcare GmbH
29. Medline Industries, LP
30. MELAG Medizintechnik GmbH & Co. KG
31. Merck KGaA
32. Metrex Research, LLC
33. Nice-Pak Products, Inc.
34. Olympus Corporation
35. Pal International Ltd.
36. Pfizer Inc.
37. Procter & Gamble Company
38. Professional Disposables International, Inc.
39. Reckitt Benckiser Group PLC
40. Rockline Industries Ltd.
41. S. C. Johnson & Son, Inc.
42. Sotera Health LLC
43. Sterigenics International LLC
44. Steris Corporation
45. Unicharm Corporation
46. Unilever PLC
47. Weiman Products, LLC
48. World Precision Instruments, LLC
49. Yessor Wipes